CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $64.75, moving +0.12% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 1.07%. Elsewhere, the Dow saw an upswing of 0.35%, while the tech-heavy Nasdaq appreciated by 1.74%. The company's shares have seen an increase of 4.41% over the last month, surpassing the Medical sector's gain of 4.02% and the S&P 500's gain of 2.93%. The investment community will be paying close attention to the earnings ...